Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in …

AA Al-Karmalawy, DS El-Gamil… - Journal of Enzyme …, 2023 - Taylor & Francis
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a–3g) in an attempt to improve their biological availability and …
被引用次数：7 相关文章
[HTML] nih.gov

[HTML][HTML] Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in …

AA Al-Karmalawy, DS El-Gamil… - Journal of Enzyme …, 2023 - ncbi.nlm.nih.gov
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a–3g) in an attempt to improve their biological availability and …
[PDF] scienceopen.com

[PDF][PDF] Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro …

AA Al-Karmalawy, DS El-Gamil… - JOURNAL OF …, 2023 - scienceopen.com
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a-3g) in an attempt to improve their biological availability and …

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in …

AA Al-Karmalawy, DS El-Gamil… - Journal of Enzyme …, 2023 - europepmc.org
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a–3g) in an attempt to improve their biological availability and …

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in …

AA Al-Karmalawy, DS El-Gamil… - Journal of enzyme …, 2023 - pubmed.ncbi.nlm.nih.gov
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a-3g) in an attempt to improve their biological availability and …

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in …

AA Al-Karmalawy, DS El-Gamil… - JOURNAL OF …, 2023 - search.proquest.com
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a–3g) in an attempt to improve their biological availability and …
[PDF] researchgate.net

[PDF][PDF] Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro …

AA Al-Karmalawy, DS El-Gamil… - JOURNAL OF …, 2023 - researchgate.net
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a-3g) in an attempt to improve their biological availability and …
[PDF] researchgate.net

[PDF][PDF] Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro …

AA Al-Karmalawy, DS El-Gamil… - JOURNAL OF …, 2023 - researchgate.net
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a-3g) in an attempt to improve their biological availability and …

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in …

AA Al-Karmalawy, DS El-Gamil… - Journal of Enzyme …, 2023 - europepmc.org
In this article, emulsomes (EMLs) were fabricated to encapsulate the N-(5-nitrothiazol-2-yl)-
carboxamido derivatives (3a-3g) in an attempt to improve their biological availability and …